Young Women’s Eggs: Elite and Ordinary
By Elizabeth Reis, Biopolitical Times guest contributor
| 09. 15. 2011
My college-age daughter can earn $50,000-$100,000 just for being smart, beautiful, tall, and a Harvard student. Yes, going to Harvard could actually pay off, even sooner than we might have imagined. $100,000 would go a long way toward paying her tuition and fees, a fact that she has pointed out to me many times. And all she would have to do is “donate” her eggs to an infertile couple willing to pay.
“Donate” is quite a misnomer. Young women are getting paid handsomely, though there is outrageous discrepancy between what are considered “elite” and more ordinary eggs. At the University of Oregon, where I teach, advertisements frequently appear in the student newspaper offering only $5000 for my students’ eggs. Still, many are tempted. I worry that young women are being unfairly lured by these exorbitant sums (even $5000 is a lot to a college student at a public university) to sign on to something that we can’t really be sure is safe in the long run.
One danger is ovarian hyperstimulation syndrome (OHSS), a potentially harmful condition caused by the...
Related Articles
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
